A Clinical Study Testing How Well the Medical Device HTIC (a Type of Animal-derived Collagen) Works in Treating Skin Problems, Such as Scars, Loss of Firmness, and Volume in Certain Areas of the Face and Body

Exclusion Criteria

• •1. Pregnant or breastfeeding.
• •2. Subjects that had undergone other medical invasive aesthetic treatments for the last 18 months before the enrolment.
• •3. Subjects with acne.
• •4. Subjects with seborrheic skin.
• •5. Subjects with normotonic, normoelastic, and normotrophic skin.
• •6. Subjects with autoimmune connective tissue disorders (connectivopathies).
• •7. Subjects with a tendency to develop hypertrophic or keloid scars.
• •8. Subjects undergoing immunosuppressive therapy.
• •9. Any cutaneous pathology of infectious, inflammatory, viral and vascular type affecting the treated area.
• •10. History of allergy or hypersensitivity to any component of the study devices.
• •11. Performing permanent filler in the past.
• •12. Use of any therapeutic agent for photoaging or skin rejuvenation within 15 days from the enrolment.
• •13. Smoking.
• •14. Wound healing disorders.
• •15. Participation in other clinical studies.